NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$5.08
+0.00 (+0.00%)
As of Sep 28, 10:32 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +593.9% upside
Low Target $27.20
Average Target $35.25
High Target $53.45
Current Price $5.08
Current
$5.08
Target
$35.25
$27.20 $35.25 avg $53.45
Scenario Analysis
Bear Case
$27.20
435.4%
Low target
Base Case
$35.25
+593.9%
Avg target
Bull Case
$53.45
+952.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$15.74
-67.7% from high
52-Week Low
$1.55
+227.7% from low
Target vs 52W High
$35.25
+124.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%